Functionally, assays showed that FOXD2-AS1 induced the migration and proliferation of cervical cancer cells and silencing of FOXD2-AS1 significantly inhibited cervical cancer growth in vivo. This evidence concerns the gene FOXD2 and cervical carcinoma.